Anti-HLA-DR, clone L243, is derived from the hybridization of mouse NS-1/1-Ag4 myeloma cells with spleen cells from BALB/c mice immunized with the human lymphoblastoid B-cell line RPMI8866.

共有 1 個藥物證書使用此成份

申請商
美商必帝股份有限公司台灣分公司 
適應症
含量
發證日期
2006-02-27